ITRM vs WELL · rev $390.0K vs P/E 100, rev $10.84B
Iterum Therapeutics PLC (ITRM) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
ITRM currently screens at market cap $38.6M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the ITRM and WELL stock pages for the full models.
Not investment advice.